BUNGEMAXX
LIVE

Serial Number

79251213

Owner

BUNGE SA

Attorney

Joel D. Leviton

Filing Date

Nov 22, 2018

Add to watchlist:

No watchlists yet
View on USPTO

BUNGEMAXX Trademark

Serial Number: 79251213 • Registration: 5917307

BUNGEMAXX is a trademark filed by BUNGE SA on November 22, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods). The application is currently registered and active.

Owner Contact Info

BUNGE SA (19 trademarks)

ROUTE DE FLORISSANT 13
GENEVE 1206 , CH

Entity Type: 33

BUNGE LIMITED (16 trademarks)

1391 Timberlake Manor Parkway
St. Louis, MO 63017

Entity Type: 03

Trademark Details

Filing Date

November 22, 2018

Registration Date

November 26, 2019

Published for Opposition

September 10, 2019

Goods & Services

[ Medicinal preparations for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; pharmaceutical preparations for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; ] nutraceutical preparations for therapeutic or medical use [ for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; ] dietetic foods for medical use; [ antioxidants for medical use for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; ] food supplements; [ antioxidants used as food supplements; adjuvants for medical use; ] lecithin for pharmaceutical use [ for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; vitamin preparations; preparations for medical use containing vitamins, trace elements, fatty acids, amino acids, enzymes and coenzymes, or plant extracts for medicinal use for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; food supplements of proteins, carbohydrates, ores, lipids, sterol or other nutrients including ascorbic acid, tocopherols, ] lecithin, [ vitamin E, sterols and ester sterols, glycerin, ] proteins [ , tocotrienols, squalene, carotenoids ]

Processed food preparations and dishes made with meat, [ fish, poultry, game, meat extracts, preserved, frozen, dried and cooked fruits and vegetables, jellies, jams, compotes, eggs, ] milk and milk products, edible oils and fats, and also containing [ natural components, antioxidants, carotenoids or other natural components, ascorbic acid, tocopherols, ] lecithin [ , vitamin E, sterols and ester sterols, glycerin, proteins, tocotrienols, squalene, carotenoids, not for medical use ] ; lecithin for culinary use

[ Chemical additives for use in the manufacture of cosmetics; chemical additives for use in the manufacture of pharmaceuticals; ] chemical additives for use in the manufacture of food; [ antioxidants for the manufacture of cosmetics; vitamins for the manufacture of cosmetics; chemical preparations for use in the manufacture of cosmetics; antioxidants for the manufacture of food supplements; ] proteins for the manufacture of food supplements; [ vitamins for the manufacture of food supplements; ] proteins for the food industry; [ vitamins for the food industry; ] chemical preparations for preserving foodstuffs; [ chemical additives for oils; ] oils for the preservation of food; [ vitamins for use in the manufacture of pharmaceuticals; preserving agents for the pharmaceutical industry; ] raw material, namely, lecithin for use in the manufacture of food products; lecithin for industrial purposes; lecithin for the food industry; chemical additives for the manufacture of food and beverages based on [ ascorbic acid, carbohydrate, tocopherols, ] lecithin [ , vitamin E, sterols and ester sterols, glycerin, proteins, tocotrienols, squalene, carotenoids; antioxidants for the manufacture of pharmaceutical products ]

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jul 9, 2026 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 7, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 7, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 7, 2026 REAP
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Dec 8, 2025 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Dec 8, 2025 C75A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Dec 1, 2025 EROP
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Nov 24, 2025 PR75
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 17, 2025 APRE
TEAS SECTION 71 & 15 RECEIVED
Jul 17, 2025 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 26, 2024 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 7, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 7, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 7, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 7, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 7, 2024 COAR
CHANGE OF OWNER RECEIVED FROM IB
Apr 5, 2024 CHLD
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 4, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 4, 2023 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 4, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 4, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 4, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 4, 2023 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 27, 2020 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 27, 2020 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 3, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 18, 2020 FICS
FINAL DISPOSITION PROCESSED
Mar 18, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 26, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 26, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 10, 2019 NPUB
PUBLISHED FOR OPPOSITION
Sep 10, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 21, 2019 NONP
ASSIGNED TO LIE
Aug 8, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 29, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 29, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 29, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 29, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 26, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 25, 2019 TROA
REFUSAL PROCESSED BY IB
Mar 29, 2019 RFNT
CHANGE OF OWNER RECEIVED FROM IB
Mar 15, 2019 CHLD
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 9, 2019 RFCS
REFUSAL PROCESSED BY MPU
Mar 9, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 1, 2019 RFCR
NON-FINAL ACTION WRITTEN
Feb 28, 2019 CNRT
ASSIGNED TO EXAMINER
Feb 25, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 15, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 7, 2019 REPR